Moderna says its new vaccine booster shows 'superior' response to Omicron
The "bivalent" vaccine — meaning it targets two different antigens — is Moderna's leading candidate to have an effective booster ready for fall of 2022, the company said. http://dlvr.it/SRqfVl
No comments:
Post a Comment